Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.

Roca A, Bojang A, Bottomley C, Gladstone RA, Adetifa JU, Egere U, Burr S, Antonio M, Bentley S, Kampmann B; Pneumo13 Study Group.

Vaccine. 2015 Dec 16;33(51):7144-51. doi: 10.1016/j.vaccine.2015.11.012. Epub 2015 Nov 17.

2.

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.

Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC.

Vaccine. 2015 Apr 21;33(17):2015-21. doi: 10.1016/j.vaccine.2015.03.012. Epub 2015 Mar 14.

3.

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.

Trück J, Snape MD, Tatangeli F, Voysey M, Yu LM, Faust SN, Heath PT, Finn A, Pollard AJ.

PLoS One. 2014 Mar 11;9(3):e91413. doi: 10.1371/journal.pone.0091413. eCollection 2014.

4.

Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel.

Regev-Yochay G, Rahav G, Riesenberg K, Wiener-Well Y, Strahilevitz J, Stein M, Glikman D, Weber G, Potasman I, Dagan R; IAIPD study group.

PLoS One. 2014 Feb 7;9(2):e88406. doi: 10.1371/journal.pone.0088406. eCollection 2014.

5.

Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children.

Biesbroek G, Wang X, Keijser BJ, Eijkemans RM, Trzciński K, Rots NY, Veenhoven RH, Sanders EA, Bogaert D.

Emerg Infect Dis. 2014 Feb;20(2):201-10. doi: 10.3201/eid2002.131220.

6.

Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial.

Roca A, Dione MM, Bojang A, Townend J, Egere U, Darboe O, Howie SR, Hill PC, Adegbola RA, Greenwood BM, Antonio M.

PLoS One. 2013 Sep 27;8(9):e72198. doi: 10.1371/journal.pone.0072198. eCollection 2013.

7.

Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.

van der Linden M, Reinert RR, Kern WV, Imöhl M.

BMC Infect Dis. 2013 Feb 5;13:70. doi: 10.1186/1471-2334-13-70.

8.

Multivariate approach for studying interactions between environmental variables and microbial communities.

Wang X, Eijkemans MJ, Wallinga J, Biesbroek G, Trzciński K, Sanders EA, Bogaert D.

PLoS One. 2012;7(11):e50267. doi: 10.1371/journal.pone.0050267. Epub 2012 Nov 26.

9.

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.

van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, de Greeff SC, van der Ende A; Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group.

Emerg Infect Dis. 2012 Nov;18(11):1729-37. doi: 10.3201/eid1811.120329.

10.

Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Westerink MA, Schroeder HW Jr, Nahm MH.

Aging Dis. 2012 Feb;3(1):51-67. Epub 2011 Jul 20.

11.

Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media.

Sabharwal V, Figueira M, Pelton SI, Pettigrew MM.

Microbes Infect. 2012 Aug;14(9):712-8. doi: 10.1016/j.micinf.2012.02.008. Epub 2012 Mar 3.

12.

Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.

Wroe PC, Lee GM, Finkelstein JA, Pelton SI, Hanage WP, Lipsitch M, Stevenson AE, Rifas-Shiman SL, Kleinman K, Dutta-Linn MM, Hinrichsen VL, Lakoma M, Huang SS.

Pediatr Infect Dis J. 2012 Mar;31(3):249-54. doi: 10.1097/INF.0b013e31824214ac.

13.

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.

Roca A, Hill PC, Townend J, Egere U, Antonio M, Bojang A, Akisanya A, Litchfield T, Nsekpong DE, Oluwalana C, Howie SR, Greenwood B, Adegbola RA.

PLoS Med. 2011 Oct;8(10):e1001107. doi: 10.1371/journal.pmed.1001107. Epub 2011 Oct 18.

14.

Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.

Billal DS, Feng J, Leprohon P, Légaré D, Ouellette M.

BMC Genomics. 2011 Oct 17;12:512. doi: 10.1186/1471-2164-12-512.

15.

Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19.

Elberse K, Witteveen S, van der Heide H, van de Pol I, Schot C, van der Ende A, Berbers G, Schouls L.

PLoS One. 2011;6(9):e25018. doi: 10.1371/journal.pone.0025018. Epub 2011 Sep 16.

16.

Contribution of vaccines to our understanding of pneumococcal disease.

Klugman KP.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2790-8. doi: 10.1098/rstb.2011.0032.

17.

Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial.

van Gils EJ, Hak E, Veenhoven RH, Rodenburg GD, Bogaert D, Bruin JP, van Alphen L, Sanders EA.

PLoS One. 2011;6(6):e20229. doi: 10.1371/journal.pone.0020229. Epub 2011 Jun 10.

18.

Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence.

Thomas JC, Figueira M, Fennie KP, Laufer AS, Kong Y, Pichichero ME, Pelton SI, Pettigrew MM.

PLoS One. 2011 Apr 14;6(4):e18649. doi: 10.1371/journal.pone.0018649.

19.

Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands.

Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, van der Ende A, Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA.

Emerg Infect Dis. 2011 Apr;17(4):584-91. doi: 10.3201/eid1704.101115.

Supplemental Content

Support Center